- Home
- FRPH vs HUMA Comparison
FRPH vs HUMA Comparison
Compare FRPH & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- HUMA
- Stock Information
- Founded
- FRPH 1986
- HUMA 2004
- Country
- FRPH United States
- HUMA United States
- Employees
- FRPH N/A
- HUMA N/A
- Industry
- FRPH Real Estate
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- FRPH Finance
- HUMA Health Care
- Exchange
- FRPH Nasdaq
- HUMA Nasdaq
- Market Cap
- FRPH 482.5M
- HUMA 250.2M
- IPO Year
- FRPH N/A
- HUMA N/A
- Fundamental
- Price
- FRPH $24.85
- HUMA $1.53
- Analyst Decision
- FRPH
- HUMA Strong Buy
- Analyst Count
- FRPH 0
- HUMA 8
- Target Price
- FRPH N/A
- HUMA $10.88
- AVG Volume (30 Days)
- FRPH 36.5K
- HUMA 3.2M
- Earning Date
- FRPH 11-05-2025
- HUMA 11-07-2025
- Dividend Yield
- FRPH N/A
- HUMA N/A
- EPS Growth
- FRPH N/A
- HUMA N/A
- EPS
- FRPH 0.28
- HUMA N/A
- Revenue
- FRPH $32,293,999.00
- HUMA $818,000.00
- Revenue This Year
- FRPH N/A
- HUMA N/A
- Revenue Next Year
- FRPH N/A
- HUMA $1,619.38
- P/E Ratio
- FRPH $90.19
- HUMA N/A
- Revenue Growth
- FRPH 3.18
- HUMA N/A
- 52 Week Low
- FRPH $24.72
- HUMA $1.15
- 52 Week High
- FRPH $33.00
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- FRPH 39.39
- HUMA 41.55
- Support Level
- FRPH $24.96
- HUMA $1.38
- Resistance Level
- FRPH $25.77
- HUMA $1.53
- Average True Range (ATR)
- FRPH 0.48
- HUMA 0.09
- MACD
- FRPH -0.02
- HUMA 0.03
- Stochastic Oscillator
- FRPH 0.68
- HUMA 51.72
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.